Open access peer-reviewed chapter

Peculiarities of SDS-PAGE of Titin/Connectin

Written By

Ivan M. Vikhlyantsev and Zoya A. Podlubnaya

Submitted: 29 January 2018 Reviewed: 23 February 2018 Published: 05 November 2018

DOI: 10.5772/intechopen.75902

From the Edited Volume

Electrophoresis - Life Sciences Practical Applications

Edited by Oana-Maria Boldura and Cornel Baltă

Chapter metrics overview

1,240 Chapter Downloads

View Full Metrics


Titin (also known as connectin) is a giant elastic protein of striated and smooth muscles of vertebrates. The molecular weight of its isoforms is 3.0–3.7 MDa in striated muscles and 0.5–2.0 MDa in smooth muscles. Titin was discovered 40 years ago using the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). At the present time, this method has not lost its relevance but has undergone a number of modifications that improve visualization of giant titin isoforms in the gel. This chapter provides historical insights into the technical aspects of the electrophoresis methods used to identify titin and its isoforms. We focus on the peculiarities of the technique because of which titin molecules remain intact and its high molecular weight isoforms can be visualized. Electrophoretic testing of changes in titin content in muscles can be used in medical practice to diagnose pathological processes and evaluate effective approaches to their correction.


  • striated muscles
  • titin (connectin)
  • titin isoforms
  • agarose-strengthened macroporous polyacrylamide gel

1. Introduction

Titin (also known as connectin) is a giant elastic protein of striated [1, 2, 3, 4, 5, 6] and smooth [7] muscles of vertebrates. The molecular weight of its isoforms is 3.0–3.7 MDa in striated muscles and 0.5–2.0 MDa in smooth muscles [7]. Titin is the third protein in quantity (after actin and myosin) in the sarcomeres of cardiac and skeletal muscles (Figure 1). Titin molecules of about 1 μm in length and 3–4 nm in diameter [8, 9] overlap the half of the sarcomere from the M-line to the Z-line, forming a third filamentous system in myofibrils [10]. In the A-zone of the sarcomere, titin is connected with myosin filaments [11]. In the I-band of the sarcomere, some regions of the titin molecule may interact with actin filaments [12, 13], but most of the titin molecule in this zone passes freely, connecting the ends of myosin filaments with the Z-disc (Figure 1). Each half of myosin filament in sarcomere includes six titin molecules [14] with N- and C-ends overlapping in the Z- and M-line of the sarcomere, respectively [15].

Figure 1.

Sarcomere structure of vertebrate striated muscles. (A) Scheme of sarcomeric structure. Thick filaments consisting mainly of myosin are located in the A-band. Thin filaments consisting mainly of actin are located in the I-band of the sarcomere and in the A-band, where they overlap with thick filaments. The H-zone is the central part of the A-band free from thin filaments. Titin molecules are arranged from the M-line to the Z-disc of the sarcomere. Transversal bands of myosin-binding proteins (H, C, X) in the A-band of the sarcomere are indicated. (B) Microphotograph of sarcomere of demembranized rabbit lumbar muscle. Scale bar: 200 nm.

Titin molecule consists of repeating immunoglobulin-like (IgC2) and fibronectin-like (FnIII) domains. Titin also contains a kinase domain in M-line, unique sequences N2A, N2B, and PEVK in I-zone and phosphorylation sites in Z-disc, M-band, and I-band of sarcomere [15].

The giant size of titin molecule and its location in all zones of sarcomere provide a basis for polyfunctionality of this protein. It has been shown that titin is a framework for the assembly of thick filaments and the sarcomere [16, 17]; is involved in maintenance of the highly ordered sarcomere structure [18, 19]; contributes to the passive tension developed by the muscle during stretching and develops the restoring force during sarcomere shortening [20, 21, 22]; is involved in the regulation of actin-myosin interaction [2, 4, 13, 23, 24, 25, 26, 27, 28, 29, 30, 31]. The results of recent studies suggest that the elastic protein titin, as a mechanosensor (strain sensor and stress sensor), plays a key role in intracellular signaling processes and in particular, participates in the regulation of muscle gene expression and protein turnover in sarcomere [2, 6, 32, 33, 34, 35, 36, 37]. These conclusions are based on the results of investigations showing the presence in the sarcomere of mechanosensory “hotspots”: complexes of signal proteins joined by titin into a single network, the activity of which varies during muscle stretching or variations in its mechanical loading [32, 33, 34, 38]. Titin is supposed to “…sense the mechanical stimuli and transform them into biochemical signals…” [34]. Great attention is now focused on the study of titin role in cardiomyopathies and skeletal muscle diseases [2, 39, 40, 41, 42, 43, 44, 45, 46, 47].

This paper provides historical insights into the technical aspects of electrophoresis methods used to identify titin and its isoforms. We focus on the peculiarities of the technique because of which titin molecules remain intact and its high molecular weight isoforms can be visualized.


2. History of the discovery and study of titin/connectin by SDS gel electrophoresis technique

Titin was discovered in 1979 by Kuan Wang and his coauthors [48] using gel electrophoresis. In macroporous polyacrylamide gel prepared according to Etlinger et al. [49] and containing 3.2% acrylamide, three new bands were found above the myosin heavy chain: a closely spaced doublet and a singlet band with faster mobility [48]. Using crosslinked myosin heavy chains (MHC, 205 kDa) as standards, the authors were able to estimate that each of these doublet bands (1 and 2) has a Mr. ∼ 1 × 106. Proteins 1 and 2 appeared to be immunologically identical and were named titin 1 (T1) and titin 2 (T2). The third protein had Mr. ∼ 5 × 105 and was thereafter named nebulin [50].

Another group of investigators headed by Maruyama studied the properties of connectin – the protein they discovered [51]. The properties of connectin as a protein candidate for the elastic filaments in sarcomeres of striated muscles of vertebrate animals were intensively explored by this group of authors in the late 1970s [52, 53, 54]. In 1981, having conducted a comparative study of electrophoretic mobility, amino acid composition, and localization in myofibrils of titin and connectin, Maruyama and coauthors showed that the major high molecular weight component of connectin was identical with that of titin [55]. Using 1.8–3.0% polyacrylamide tube gels prepared according to Weber and Osborn [56], and crosslinked MHC as standards, the authors showed that the molecular weights of α-connectin (corresponding to intact molecules of titin-1) and β-connectin (corresponding to proteolytic fragments of T1–T2) of breast muscle of the chicken were 2.8 × 106 and 2.1 × 106, respectively [57].

Further electrophoretic studies of titin (connectin) using different types of gels (1.8% or 2.3–4% polyacrylamide tube gels, 2–12% gradient polyacrylamide slab gel) [58, 59, 60, 61, 62, 63]) revealed differences in electrophoretic mobility of T1 (α-connectin) in cardiac and skeletal muscles of vertebrates animals (fishes, amphibians, reptiles, birds, mammals). In particular, plots of molecular mass versus mobility, assuming 2.8 and 2.4 MDa for T1 and T2 of the rabbit psoas, respectively, yielded the following set of values for T1: 2.8 MDa (adductor magnus), 2.88 MDa (longissimus dorsi, sartorius), 2.94 MDa (soleus, semitendinosus) [60]. Cardiac muscle displayed the smallest titin. Similar data were obtained by us using 2.5–9% gradient polyacrylamide slab gel (Figure 2). Based on data obtained the assumption on the existence of isoforms of T1 was made [60, 61].

Figure 2.

Molecular weights of T1 isoforms from rabbit striated muscles. Electrophoresis was performed in a gradient 2.5–9.0% polyacrylamide vertical gel (8 × 10 × 0.1 cm). (1) myocardium (left ventricle); (2) m. soleus; (3) logarithmic dependence of molecular weight on protein electrophoretic mobility in gel. T1 molecular weight was assessed by the following standards: Cardiac MyBP-C (150 kDa), as well as myosin heavy chains (MHC, 205 kDa), nebulin (770 kDa), and T2-fragment (2400 kDa) of rabbit skeletal muscles [60, 87, 88].

In 1995, the complete complementary DNA sequence of human cardiac titin was determined [64]. Further studies showed that the titin gene (TTN) consists of 363 coding exons, which can be differentially spliced and theoretically could generate more than one million splice variants in striated and smooth muscles of mammals [7, 65, 66, 67, 68]. Adult striated muscles express three major titin isoforms: N2A in skeletal muscles (3.35–3.7 MDa), N2B, and N2BA in cardiac muscle (2.97–3.3 MDa, respectively) [65].

2.1. Electrophoretic detection of titin isoforms

To confirm that muscles contain N2A, N2B, and N2BA isoforms of titin, different macroporous gels (2–9.5% gradient polyacrylamide slab gel, 1% agarose slab gel, agarose-strengthened 2% polyacrylamide slab gel, horizontal 1.3% polyacrylamide gel strengthened with 0.5% agarose) were used [69, 70, 71, 72, 73]. It was shown that the T1 mobility varied greatly between skeletal and cardiac muscles from different mammals. The major T1 bands were ascribed to the titin isoforms N2B and N2BA in cardiac muscle and the titin isoform N2A in skeletal muscles. According to Western blot data with using antibodies against the N-terminal and the C-terminal ends of titin, it was revealed that the N2A, N2B, and N2BA bands represent full-length titin molecules (titin 1 – T1) [69, 74].

Titin isoform analyses for 37 adult rabbit skeletal muscles showed sizes between 3.3 and 3.7 MDa [75]. N2BA titin isoforms in cardiac muscle of different mammals had sizes between 3.25 and 3.4 MDa [72].

Using 1% vertical agarose gel [70] at least four classes of cardiac N2BA titin isoforms were observed, of which two rat embryonic/neonatal forms (N2BA-N1, N2BA-N2) had sizes of 3710 and 3590 kDa. These isoforms were found during late embryonic and immediately post-natal period [76]. These were gradually replaced by adult forms (N2BA-A1, N2BA-A2) with sizes of 3390 and 3220 kDa, respectively [76]. Similar titin isoform transformations were observed in embryonic/neonatal hearts of rat and other mammals and reported by the researchers [74, 77, 78, 79, 80].

Giant titin isoforms expressed in rat striated muscles with an RBM20 autosomal dominant mutation were reported [81, 82, 83]. The molecular masses of these isoforms were estimated from their electrophoretic mobility in 1% vertical agarose gel to be 3750 and 3830 kDa [83].

2.2. New high molecular weight forms of titin in striated muscles of mammals: aggregates or intact isoforms?

Our group headed by Zoya Podlubnaya conducts a comparative study of titin isoform composition in mammalian striated muscles under conditions of hibernation, microgravity, and during the development of pathological processes [84]. Vertical agarose-strengthened 2.2% polyacrylamide gel prepared according to Tatsumi and Hattori [85] was used to separate titin isoforms and their fragments.

Our first experiments, conducted more than 10 years ago, showed that, in addition to N2A, N2BA, N2B and T2 bands, there exist one or two more high Mr. bands (named NT) [84, 86]. Staining the gels with ethidium bromide revealed no nucleic acids in the bands, although western blots with 9D10 antibodies revealed titin bands. The bands were visualized in the electropherograms of striated muscles of mammals, but in the electropherograms of striated muscles in other groups of vertebrates (amphibians and birds) revealed no NT bands [84].

The content of NT titins in muscles of animals and humans was as follows: Mongolian gerbil (8–14%), mouse (13–18%), rat (9–26%), rabbit (13–30%), ground squirrel (24–33%), and human (29–41%) [73, 84]. Using human and animal skeletal muscle myosin heavy chain (205 kDa) and nebulin (770–890 kDa), as well as the N2A titin isoform (∼3600 and 3700 kDa) of rabbit and human soleus as standards [60, 75, 87, 88], we estimated that the NT has a Mr. of ∼3.8–3.9 × 106 [73]. Expression of titin isoforms with these molecular weights is not excluded [66, 67, 82, 83], but titin aggregates in gels could not be excluded either [69, 88]. Data published in 2003 demonstrated in electropherograms of the dog heart left ventricle, together with the known N2BA and N2B isoforms and T2-fragments of titin, the presence of higher molecular weight double protein bands that were named titin aggregates [70].

We were also not absolutely sure that titin NT bands were not aggregates of its lower molecular weight isoforms and their fragments. If this were so, then the proteolytic cleavage of titin accompanied by an increase in the content of its fragments must result in the higher content of aggregates. Experiments on proteolytic cleavage of titin in muscle tissue under the influence of endogenous proteases were performed to test this assumption [84] (Figure 3).

Figure 3.

Proteolytic changes in titin in ground squirrel muscles. Electrophoresis was performed in vertical agarose-strengthened 2.1% polyacrylamide gel (8 × 10 × 0.1 cm). (1) m. soleus (control); (2) m. soleus (proteolysis, 1 h); (3) left ventricle of heart (control); (4) left ventricle of heart (proteolysis, 30 min). Proteolytic cleavage of titin was performed under the influence of endogenous muscular proteases. To this end, small pieces of muscle tissue (20–30 mg) were held for 30–60 min at 25–30°C. Then, 2–3 mg pieces were taken from the muscle sample and placed into solubilizing solution (10 mM Tris–HCl, 1.2% SDS, 10% glycerol, 2% β-mercaptoethanol or 75 mM DTT, 8–10 μg/ml of leupeptin or E64, pH 7.0) for the extraction and further electrophoretic testing of the proteins. T3300 is probably the proteolytic fragment of NT titin with molecular weight of ~3300 kDa.

It was found that proteolysis of titin in m. soleus for 30–60 min resulted in a reduction (sixfold to sevenfold) of the content of NT titin and twofold reduction of the content of N2A titin (Figure 3, lanes 1 and 2). At the same time, a considerable increase in the content of T2 and appearance of a band with a molecular weight of ~3200–3300 kDa (T3300) were detected, which is probably a product of NT titin degradation.

Proteolysis of titin in cardiac muscle for 30–60 min resulted in a 2–3-fold decrease in the content of NT and N2BA (Figure 3, lanes 3 and 4). At the same time, the increase in the content of not only T2-fragments but also N2B isoform of titin was observed, which could be explained by the presence of fragments of NT and N2BA titins in this protein band. Densitometry data showed that the total titin content (relative to MHC content) in muscles as a result of 30–60 min proteolysis has not changed.

Thus, the results did not confirm our assumption that NT bands are aggregates of lower molecular weight titin isoforms and their fragments. However, these data did not exclude the aggregative origin of NT bands. Assuming that molecular masses of titin aggregates should considerably exceed 3800–3900 kDa, we decided to find out more about the differences in electrophoretic mobility of the observed bands. We developed a horizontal agarose-strengthened gel system using 1.3% polyacrylamide and 0.5% agarose [73].The gels showed that mobility of the NT bands, as well as other titin bands, varied greatly in different muscles.

Using human and animal skeletal muscle nebulin (770–890 kDa) as well as MHC (205 kDa) as standards the molecular masses of N2A, N2BA, N2B, T2, and NT titin bands were estimated. The results obtained were unexpected for us. The NT bands had sizes between 3230 and 3730 kDa, whereas the N2A, N2BA, N2B, and T2 bands had sizes between 2100 and 2800 kDa [73, 84]. The last values corresponded to a set of values for T1 (α-connectin) and T2 (β-connectin) [57, 60, 88]. Similar data were obtained for vertical agarose-strengthened 1.9% polyacrylamide gels (Figure 4). The gel resolved a doublet NT band at 3300–3400 kDa for cardiac muscle and a singlet band of 3600–3700 kDa for skeletal muscles of mammals.

Figure 4.

SDS-PAGE analysis of titin isoforms in striated muscles of ground squirrel (Spermophilus undulatus); a modified view from [89]. Vertical agarose-strengthened 1.9% polyacrylamide gel (14.5 × 16.0 × 0.15 cm) was used to separate the titin isoforms. (1) Myocardium (left ventricle); (2) m. soleus. T1 molecular weight was assessed by the following standards: MHC (205 kDa), nebulin (770–890 kDa), titin-2 (2100–2400 kDa) of rabbit and human striated muscles [60, 87, 88].

Results from western blots with Z1/Z2 antibodies against the N-terminal end and AB5 antibodies against the C-terminal end of titin revealed the NT bands were full-length titin molecules [89] (Figure 5). We, therefore, hypothesized that the NT bands are intact N2A, N2BA, N2B titin isoforms [89]. Although this requires further research, we cannot exclude the possibility that the NT bands are the other protein immunologically identical to titin, for example, a protein whose long thin filaments were revealed in the “shades” of rabbit psoas myofibrils remaining after sequential removal of myosin, actin, tropomyosin, troponins, and the minor M-band proteins [90] (Figure 6).

Figure 5.

Western blotting of titin in striated muscles of ground squirrel; a modified view from [89]. As primary antibodies, the following were used: Z1/Z2 to N-end of titin molecule located in Z-disc of sarcomere (1, 2); AB5 to the part of titin molecule in A-disk located near the M-line of sarcomere (3,4); (1,4) m. soleus; (2,3) myocardium (left ventricle).

Figure 6.

Microphotograph of isolated negatively stained myofibril of rabbit lumbar muscle after the extraction of myosin and actin filaments. The remaining “Z-discs” are kept in the register by longitudinal filaments continually passing through the entire myofibril (indicated by the arrow). Scale bar: 100 nm.

2.3. Nuances of sample preparation of titin

In the paper of Granzier and Wang [88], particular attention was paid to sample preparation of titin. The authors pointed to the fact that titin is extraordinarily sensitive to proteolysis in situ by endogenous proteases and by exogenous proteases such as those found in buffers that are contaminated with bacteria and fungi. According to these and other authors, even in SDS-solubilized myofibril samples, appreciable degradation of titin by residual protease activity can occur in a few days at room temperature [50, 88, 91].

To limit proteolysis, a number of authors suggested the inclusion of protease inhibitors in SDS samples prior to electrophoresis. Leupeptin, E-64, and a protease inhibitor cocktail have been used to inhibit proteolytic degradation of titin [21, 70, 72, 73, 85, 92]. In order to attain better solubilization of titin, it has been proposed to use urea-thiourea SDS DTT sample buffer [70, 93].

Another crucial methodical nuance that should be taken into account during sample`s preparation of titin is heat treatment of the samples. SDS samples are usually prepared by heating them in boiling water for several minutes. This process promotes denaturation of proteins and facilitates disulfide reduction. However, different authors have shown that boiling degrades titin [70, 88, 94, 95]. Samples heated at 100°C had less intact titin and more breakdown products (smears migrating near the bottom of the gel) than those at 60°C [70]. A temperature of 50–60°C for 10–20 min has been considered optimal for the extraction and preservation of intact titin [70, 88, 95]. Results of our studies demonstrated that heating of SDS sample at the said temperature may lead to artifacts in the content of titin. SDS samples of mammalian cardiac muscle heated at 60−65°C for 20 min had another N2BA/N2B ratio than those at 30–40°C [96]. We recommended heating titin in SDS at 35–40°C for 30–40 min [73, 84].

2.4. Other details of the electrophoretic study of titin

It is suggested that titin has a tendency to aggregate during electrophoresis, especially in gel systems that use a stacking gel or discontinuous buffers [88]. Fritz et al. [93], as well as Greaser and Warren [97, 98], recommended the inclusion of β-mercaptoethanol in the top anodic buffer to prevent disulfide crosslinking.

There is some peculiarity that should be noted with regard to the preparation of agarose-strengthened 2% polyacrylamide gel. Tatsumi and Hattori [85] to prevent polyacrylamide polymerizing before agarose is polymerized, cooled the glass cell with agarose solution (40°C) for 5 min in ice water. Similarly, we added the agarose solution to glass cells that were pre-cooled to 8–10°C and left the gel for 10 min in the refrigerator at 5°C. Then, we kept the gel for 30 min at 20°C and then for 2–2.5 h at 27°C.

It is recommended to perform electrophoresis using macroporous, agarose-strengthened polyacrylamide gels at low currents. Neagoe (of Wolfgang Linke’s group) noted that the best separation of the high molecular weight proteins was obtained by running the electrophoresis overnight at 2 mA per 8.6 × 7.7 cm gel [99]. In our studies with the use of similar gels (8.0 × 10.0 × 0.10 cm), we perform electrophoresis at 3 mA for 40 min, then increasing the current strength up to 7–8 mA [96].

Granzier and Wang recommended to refresh the tank buffer once at 2.5 h to limit pH changes caused by electrolysis during electrophoresis [88].


3. Conclusion

In summary, it should be noted that SDS-PAGE of titin is quite difficult and not a routine procedure. Giant molecular mass and the susceptibility of titin to degrade during preparation significantly complicate the study of this protein by electrophoresis. It is necessary to know the three main rules for a successful study of titin by electrophoresis: (1) use protease inhibitors (leupeptin, E-64, protease inhibitor cocktail); (2) do not heat SDS samples higher than 40–60°C; and (3) judiciously select the type of the gel. Currently, the most suitable gels for analyzing titin are the following: (1) vertical agarose-strengthened 2% polyacrylamide gel [85]; (2) vertical 1% agarose gel [70]; and (3) horizontal agarose-strengthened 1.3% polyacrylamide gel [73].

It should be noted that we have obtained experimental evidence of existence in mammalian striated muscles of higher molecular weight isoforms of titin, named NT. According to our data, the development of pathological processes leads to the destruction of NT titins (Figure 7), which is accompanied by disorders of sarcomeric structure and impairment of the contractile ability of muscles [84]. In addition to fundamental value, these findings are of great practical value, because the testing of changes in titin content in muscles can be used in medical practice to diagnose pathological processes and evaluate effective approaches to their correction.

Figure 7.

Increased proteolysis of titin and reduction of T1 content in m. Soleus of post-apoplectic patient. Vertical agarose-strengthened 2.3% polyacrylamide gel (8.0 × 10.0 × 0.10 cm) was used to separate titin isoforms. (1) Human m. soleus (control); (2) m. soleus of post-apoplectic patient.



The authors are grateful to Drs. L. A. Tskhovrebova and J. Trinick for kindly providing the antibodies against titin. The authors also thank Sergey Udaltsov for helpful discussions on electrophoretic techniques. This work was financially supported by the Russian Foundation for Basic Research (project No. 17-04-00326) and by the Russian Science Foundation (project No. 18-15-00062).

† In memoriam to Dr. Zoya Podlubnaya.


Conflict of interest

Ivan M. Vikhlyantsev and Zoya A. Podlubnaya declare that there is no conflicts of interest.


  1. 1. Tskhovrebova L, Trinick J. Titin and Nebulin in thick and thin filament length regulation. Sub-Cellular Biochemistry. 2017;82:285-318. DOI: 10.1007/978-3-319-49674-0_10
  2. 2. Linke WA. Titin gene and protein functions in passive and active muscle. Annual Review of Physiology. 2018;80:389-411. DOI: 10.1146/annurev-physiol-021317-121234
  3. 3. Tonino P, Kiss B, Strom J, Methawasin M, Smith JE 3rd, Kolb J, Labeit S, Granzier H. The giant protein titin regulates the length of the striated muscle thick filament. Nature Communications. 2017;8(1):1041. DOI: 10.1038/s41467-017-01144-9
  4. 4. Herzog W. The multiple roles of titin in muscle contraction and force production. Biophysical Reviews. 2018. DOI: 10.1007/s12551-017-0395-y. [Epub ahead of print]
  5. 5. Gautel M, Djinović-Carugo K. The sarcomeric cytoskeleton: From molecules to motion. The Journal of Experimental Biology. 2016;219(Pt 2):135-145. DOI: 10.1242/jeb.124941
  6. 6. LeWinter MM, Granzier HL. Cardiac titin and heart disease. Journal of Cardiovascular Pharmacology. 2014;63(3):207-212. DOI: 10.1097/FJC.0000000000000007
  7. 7. Labeit S, Lahmers S, Burkart C, Fong C, McNabb M, Witt S, Witt C, Labeit D, Granzier H. Expression of distinct classes of titin isoforms in striated and smooth muscles by alternative splicing, and their conserved interaction with filamins. Journal of Molecular Biology. 2006;362(4):664-681
  8. 8. Suzuki J, Kimura S, Maruyama K. Electron microscopic filament lengths of connection and its fragments. Journal of Biochemistry. 1994;116(2):406-410
  9. 9. Tskhovrebova L, Trinick J. Direct visualization of extensibility in isolated titin molecules. Journal of Molecular Biology. 1997;265(2):100-106
  10. 10. Fürst DO, Nave R, Osborn M, Weber K. Repetitive titin epitopes with a 42 nm spacing coincide in relative position with known a band striations also identified by major myosin-associated proteins. An immunoelectron-microscopical study on myofibrils. Journal of Cell Science. 1989;94(Pt 1):119-125
  11. 11. Houmeida A, Holt J, Tskhovrebova L, Trinick J. Studies of the interaction between titin and myosin. The Journal of Cell Biology. 1995;131(6 Pt 1):1471-1481
  12. 12. Trombitás K, Pollack GH. Elastic properties of the titin filament in the Z-line region of vertebrate striated muscle. Journal of Muscle Research and Cell Motility. 1993;14(4):416-422
  13. 13. Kulke M, Fujita-Becker S, Rostkova E, Neagoe C, Labeit D, Manstein DJ, Gautel M, Linke WA. Interaction between PEVK-titin and actin filaments: Origin of a viscous force component in cardiac myofibrils. Circulation Research. 2001;89(10):874-881
  14. 14. Liversage AD, Holmes D, Knight PJ, Tskhovrebova L, Trinick J. Titin and the sarcomere symmetry paradox. Journal of Molecular Biology. 2001;305(3):401-409
  15. 15. Gregorio CC, Granzier H, Sorimachi H, Labeit S. Muscle assembly: A titanic achievement? Current Opinion in Cell Biology. 1999;11(1):18-25
  16. 16. Peckham M, Young P, Gautel M. Constitutive and variable regions of Z-disk titin/connectin in myofibril formation: A dominant-negative screen. Cell Structure and Function. 1997;22(1):95-101
  17. 17. van der Ven PF, Bartsch JW, Gautel M, Jockusch H, Fürst DO. A functional knock-out of titin results in defective myofibril assembly. Journal of Cell Science. 2000;113(Pt 8):1405-1414
  18. 18. Horowits R, Kempner ES, Bisher ME, Podolsky RJ. A physiological role for titin and nebulin in skeletal muscle. Nature. 1986;323(6084):160-164
  19. 19. Higuchi H. Changes in contractile properties with selective digestion of connectin (titin) in skinned fibers of frog skeletal muscle. Journal of Biochemistry. 1992;111(3):291-295
  20. 20. Linke WA, Popov V, Pollack GH. Passive and active tension in single cardiac myofibrils. Biophysical Journal. 1994;67(2):782-792
  21. 21. Granzier HL, Irving TC. Passive tension in cardiac muscle: Contribution of collagen, titin, microtubules, and intermediate filaments. Biophysical Journal. 1995;68(3):1027-1044
  22. 22. Helmes M, Trombitás K, Granzier H. Titin develops restoring force in rat cardiac myocytes. Circulation Research. 1996;79(3):619-626
  23. 23. Kimura S, Maruyama K, Huang YP. Interactions of muscle beta-connectin with myosin, actin, and actomyosin at low ionic strengths. Journal of Biochemistry. 1984;96(2):499-506
  24. 24. Cazorla O, Vassort G, Garnier D, Le Guennec JY. Length modulation of active force in rat cardiac myocytes: Is titin the sensor? Journal of Molecular and Cellular Cardiology. 1999;31(6):1215-1227
  25. 25. Podlubnaya ZA, Shpagina MD, Vikhlyantsev IM, Malyshev SL, Udaltsov SN, Ziegler C, Beinbrech G. Comparative electron microscopic study on projectin and titin binding to F-actin. Insect Biochemistry and Molecular Biology. 2003;33(8):789-793
  26. 26. Vikhlyantsev IM, Podlubnaya ZA. Phosphorylation of sarcomere cytoskeletal proteins as an adaptive factor of inhibiting the contractile activity of muscle in hibernation. Biophysics. 2003;48(3):471-476
  27. 27. Niederländer N, Raynaud F, Astier C, Chaussepied P. Regulation of the actin-myosin interaction by titin. European Journal of Biochemistry. 2004;271(22):4572-4581
  28. 28. Bianco P, Nagy A, Kengyel A, Szatmári D, Mártonfalvi Z, Huber T, Kellermayer MS. Interaction forces between F-actin and titin PEVK domain measured with optical tweezers. Biophysical Journal. 2007;93(6):2102-2109
  29. 29. Fukushima H, Chung CS, Granzier H. Titin-isoform dependence of titin-actin interaction and its regulation by S100A1/Ca2+ in skinned myocardium. Journal of Biomedicine & Biotechnology. 2010;2010:727239. DOI: 10.1155/2010/727239
  30. 30. Vikhlyantsev IM, Okuneva AD, Shpagina MD, Shumilina YV, Molochkov NV, Salmov NN, Podlubnaya ZA. Changes in isoform composition, structure, and functional properties of titin from Mongolian gerbil (Meriones unguiculatus) cardiac muscle after space flight. Biochemistry (Mosc). 2011;76(12):1312-1320. DOI: 10.1134/S0006297911120042
  31. 31. Li Y, Lang P, Linke WA. Titin stiffness modifies the force-generating region of muscle sarcomeres. Scientific Reports. 2016;6:24492. DOI: 10.1038/srep24492
  32. 32. Tskhovrebova L, Trinick J. Muscle disease: A giant feels the strain. Nature Medicine. 2005;11(5):478-479
  33. 33. Lange S, Xiang F, Yakovenko A, Vihola A, Hackman P, Rostkova E, Kristensen J, Brandmeier B, Franzen G, Hedberg B, Gunnarsson LG, Hughes SM, Marchand S, Sejersen T, Richard I, Edström L, Ehler E, Udd B, Gautel M. The kinase domain of titin controls muscle gene expression and protein turnover. Science. 2005;308(5728):1599-1603
  34. 34. Voelkel T, Linke WA. Conformation-regulated mechanosensory control via titin domains in cardiac muscle. Pflügers Archiv. 2011;462(1):143-154. DOI: 10.1007/s00424-011-0938-1
  35. 35. Gautel M. The sarcomeric cytoskeleton: Who picks up the strain? Current Opinion in Cell Biology. 2011;23(1):39-46. DOI: 10.1016/
  36. 36. Gautel M. Cytoskeletal protein kinases: Titin and its relations in mechanosensing. Pflügers Archiv. 2011;462(1):119-134. DOI: 10.1007/s00424-011-0946-1
  37. 37. Krysiak J, Unger A, Beckendorf L, Hamdani N, von Frieling-Salewsky M, Redfield MM, Dos Remedios CG, Sheikh F, Gergs U, Boknik P, Linke WA. Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes. Nature Communications. 2018;9(1):262. DOI: 10.1038/s41467-017-02483-3
  38. 38. Linke WA, Krüger M. The giant protein titin as an integrator of myocyte signaling pathways. Physiology (Bethesda). 2010;25(3):186-198. DOI: 10.1152/physiol.00005.2010
  39. 39. Gerull B. Between disease-causing and an innocent bystander: The role of titin as a modifier in hypertrophic cardiomyopathy. The Canadian Journal of Cardiology. 2017;33(10):1217-1220. DOI: 10.1016/j.cjca.2017.07.010
  40. 40. Hessel AL, Nishikawa KC. Effects of a titin mutation on negative work during stretch-shortening cycles in skeletal muscles. Experimental Biology. 2017;220(Pt22):4177-4185. DOI: 10.1242/jeb.163204
  41. 41. Tayal U, Newsome S, Buchan R, Whiffin N, Halliday B, Lota A, Roberts A, Baksi AJ, Voges I, Midwinter W, Wilk A, Govind R, Walsh R, Daubeney P, Jarman JWE, Baruah R, Frenneaux M, Barton PJ, Pennell D, Ware JS, Prasad SK, Cook SA. Phenotype and clinical outcomes of titin cardiomyopathy. Journal of the American College of Cardiology. 2017;70(18):2264-2274. DOI: 10.1016/j.jacc.2017.08.063
  42. 42. Vikhorev PG, Smoktunowicz N, Munster AB, Copeland O, Kostin S, Montgiraud C, Messer AE, Toliat MR, Li A, Dos Remedios CG, Lal S, Blair CA, Campbell KS, Guglin M, Knoll R, Marston SB. Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Scientific Reports. 2017;7(1):14829. DOI: 10.1038/s41598-017-13675-8
  43. 43. Gritsyna YV, Salmov NN, Bobylev AG, Ulanova AD, Kukushkin NI, Podlubnaya ZA, Vikhlyantsev IM. Increased autolysis of μ-Calpain in skeletal muscles of chronic alcohol-fed rats. Alcoholism, Clinical and Experimental Research. 2017;41(10):1686-1694. DOI: 10.1111/acer.13476
  44. 44. Ehsan M, Jiang H, L Thomson K, Gehmlich K. When signalling goes wrong: Pathogenic variants in structural and signalling proteins causing cardiomyopathies. Journal of Muscle Research and Cell Motility. 2017;38(3-4):303-316. DOI: 10.1007/s10974-017-9487-3
  45. 45. Ware JS, Cook SA. Role of titin in cardiomyopathy: From DNA variants to patient stratification. Nature Reviews Cardiology. 2017;14. DOI: 10.1038/nrcardio.2017.190
  46. 46. Tasca G, Udd B. Hereditary myopathy with early respiratory failure (HMERF): Still rare, but common enough. Neuromuscular Disorders. 2017;12. pii: S0960-8966(17)31223-3. DOI: 10.1016/j.nmd.2017.12.002
  47. 47. Rexiati M, Sun M, Guo W. Muscle-specific Mis-splicing and heart disease exemplified by RBM20. Genes (Basel). 2018;9(1):1-13. pii: E18. DOI: 10.3390/genes9010018
  48. 48. Wang K, McClure J, Tu A. Titin: Major myofibrillar components of striated muscle. Proceedings of the National Academy of Sciences of the United States of America. 1979;76(8):3698-3702
  49. 49. Etlinger JD, Zak R, Fischman DA. Compositional studies of myofibrils from rabbit striated muscle. The Journal of Cell Biology. 1976;68(1):123-141
  50. 50. Wang K. Purification of titin and nebulin. Methods Enzymol. 1982;85 Pt B:264-274
  51. 51. Maruyama K, Natori R, Nonomura Y. New elastic protein from muscle. Nature. 1976;262(5563):58-60
  52. 52. Maruyama K, Matsubara S, Natori R, Nonomura Y, Kimura S. Connectin, an elastic protein of muscle. Characterization and function. Journal of Biochemistry. 1977;82(2):317-337
  53. 53. Matsubara S, Maruyama K. Role of connectin in the length-tension relation of skeletal and cardiac muscles. The Japanese Journal of Physiology. 1977;27(5):589-600
  54. 54. Toyoda N, Maruyama K. Fine structure of connectin nets in cardiac myofibrils. Journal of Biochemistry. 1978;84(1):239-241
  55. 55. Maruyama K, Kimura S, Ohashi K, Kuwano Y. Connectin, an elastic protein of muscle. Identification of “titin” with connectin. Journal of Biochemistry. 1981;89(3):701-709
  56. 56. Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. The Journal of Biological Chemistry. 1969;244(16):4406-4412
  57. 57. Maruyama K, Kimura S, Yoshidomi H, Sawada H, Kikuchi M. Molecular size and shape of beta-connectin, an elastic protein of striated muscle. Journal of Biochemistry. 1984 May;95(5):1423-1433
  58. 58. Hu DH, Kimura S, Maruyama K. Sodium dodecyl sulfate gel electrophoresis studies of connectin-like high molecular weight proteins of various types of vertebrate and invertebrate muscles. Journal of Biochemistry. 1986 May;99(5):1485-1492
  59. 59. Wang K, Wright J. Architecture of the sarcomere matrix of skeletal muscle: Immunoelectron microscopic evidence that suggests a set of parallel inextensible nebulin filaments anchored at the Z line. The Journal of Cell Biology. 1988;107(6 Pt 1):2199-2212
  60. 60. Wang K, McCarter R, Wright J, Beverly J, Ramirez-Mitchell R. Regulation of skeletal muscle stiffness and elasticity by titin isoforms: A test of the segmental extension model of resting tension. Proceedings of the National Academy of Sciences of the United States of America. 1991;88(16):7101-7105
  61. 61. Horowits R. Passive force generation and titin isoforms in mammalian skeletal muscle. Biophysical Journal. 1992 Feb;61(2):392-398
  62. 62. Kawamura Y, Ohtani Y, Maruyama K. Biodiversity of the localization of the epitopes to connectin antibodies in the sarcomeres of lamprey, electric ray, and horse mackerel skeletal muscles. Tissue & Cell. 1994;26(5):677-685
  63. 63. Spierts IL, Akster HA, Granzier HL. Expression of titin isoforms in red and white muscle fibres of carp (Cyprinus carpio L.) exposed to different sarcomere strains during swimming. Journal of Comparative Physiology B. 1997;167(8):543-551
  64. 64. Labeit S, Kolmerer B. Titins: Giant proteins in charge of muscle ultrastructure and elasticity. Science. 1995;270(5234):293-296
  65. 65. Freiburg A, Trombitas K, Hell W, Cazorla O, Fougerousse F, Centner T, Kolmerer B, Witt C, Beckmann JS, Gregorio CC, Granzier H, Labeit S. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circulation Research. 2000;86(11):1114-1121
  66. 66. Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circulation Research. 2001;89(11):1065-1072
  67. 67. Guo W, Bharmal SJ, Esbona K, Greaser ML. Titin diversity–alternative splicing gone wild. Journal of Biomedicine & Biotechnology. 2010;2010:753675. DOI: 10.1155/2010/753675
  68. 68. Gerull B. The rapidly evolving role of titin in cardiac physiology and cardiomyopathy. The Canadian Journal of Cardiology. 2015;31(11):1351-1359. DOI: 10.1016/j.cjca.2015.08.016
  69. 69. Cazorla O, Freiburg A, Helmes M, Centner T, McNabb M, Wu Y, Trombitás K, Labeit S, Granzier H. Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circulation Research. 2000;86(1):59-67
  70. 70. Warren CM, Krzesinski PR, Greaser ML. Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins. Electrophoresis. 2003;24(11):1695-1702
  71. 71. Warren CM, Jordan MC, Roos KP, Krzesinski PR, Greaser ML. Titin isoform expression in normal and hypertensive myocardium. Cardiovascular Research. 2003;59(1):86-94
  72. 72. Neagoe C, Opitz CA, Makarenko I, Linke WA. Gigantic variety: Expression patterns of titin isoforms in striated muscles and consequences for myofibrillar passive stiffness. Journal of Muscle Research and Cell Motility. 2003;24(2-3):175-189
  73. 73. Vikhlyantsev IM, Podlubnaya ZA. On the titin isoforms. Biophysics. 2006;51(5):842-848
  74. 74. Lahmers S, Wu Y, Call DR, Labeit S, Granzier H. Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium. Circulation Research. 2004;94(4):505-513
  75. 75. Prado LG, Makarenko I, Andresen C, Krüger M, Opitz CA, Linke WA. Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles. The Journal of General Physiology. 2005;126(5):461-480
  76. 76. Warren CM, Krzesinski PR, Campbell KS, Moss RL, Greaser ML. Titin isoform changes in rat myocardium during development. Mechanisms of Development. 2004;121(11):1301-1312
  77. 77. Opitz CA, Leake MC, Makarenko I, Benes V, Linke WA. Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circulation Research. 2004;94(7):967-975. Epub 26 February 2004
  78. 78. Greaser ML, Krzesinski PR, Warren CM, Kirkpatrick B, Campbell KS, Moss RL. Developmental changes in rat cardiac titin/connectin: Transitions in normal animals and in mutants with a delayed pattern of isoform transition. Journal of Muscle Research and Cell Motility. 2005;26(6-8):325-332
  79. 79. Krüger M, Kohl T, Linke WA. Developmental changes in passive stiffness and myofilament Ca2+ sensitivity due to titin and troponin-I isoform switching are not critically triggered by birth. American Journal of Physiology. Heart and Circulatory Physiology. 2006;291(2):H496-H506
  80. 80. Vikhlyantsev IM, Podlubnaya ZA. Nuances of electrophoresis study of titin/connectin. Biophysical Reviews. 2017;9(3):189-199. DOI: 10.1007/s12551-017-0266-6
  81. 81. Greaser ML, Warren CM, Esbona K, Guo W, Duan Y, Parrish AM, Krzesinski PR, Norman HS, Dunning S, Fitzsimons DP, Moss RL. Mutation that dramatically alters rat titin isoform expression and cardiomyocyte passive tension. Journal of Molecular and Cellular Cardiology. 2008;44(6):983-991. DOI: 10.1016/j.yjmcc.2008.02.272
  82. 82. Guo W, Schafer S, Greaser ML, Radke MH, Liss M, Govindarajan T, Maatz H, Schulz H, Li S, Parrish AM, Dauksaite V, Vakeel P, Klaassen S, Gerull B, Thierfelder L, Regitz-Zagrosek V, Hacker TA, Saupe KW, Dec GW, Ellinor PT, MacRae CA, Spallek B, Fischer R, Perrot A, Özcelik C, Saar K, Hubner N, Gotthardt M. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nature Medicine. 2012;18(5):766-773. DOI: 10.1038/nm.2693
  83. 83. Li S, Guo W, Schmitt BM, Greaser ML. Comprehensive analysis of titin protein isoform and alternative splicing in normal and mutant rats. Journal of Cellular Biochemistry. 2012;113(4):1265-1273. DOI: 10.1002/jcb.23459
  84. 84. Vikhlyantsev IM, Podlubnaya ZA. New titin (connectin) isoforms and their functional role in striated muscles of mammals: Facts and suppositions. Biochemistry (Mosc). 2012;77(13):1515-1535. DOI: 10.1134/S0006297912130093
  85. 85. Tatsumi R, Hattori A. Detection of giant myofibrillar proteins connectin and nebulin by electrophoresis in 2% polyacrylamide slab gels strengthened with agarose. Analytical Biochemistry. 1995;224(1):28-31
  86. 86. Vikhlyantsev IM, Malyshev SL, Shenkman BS, Podlubnaya ZA. Composition of the titin family proteins in skeletal muscle of ground squirrel during hibernation and rats in simulated microgravity. Biophysics. 2004;49(6):895-900
  87. 87. Kruger M, Wright J, Wang K. Nebulin as a length regulator of thin filaments of vertebrate skeletal muscles: Correlation of thin filament length, nebulin size, and epitope profile. The Journal of Cell Biology. 1991;115(1):97-107
  88. 88. Granzier HL, Wang K. Gel electrophoresis of giant proteins: Solubilization and silver-staining of titin and nebulin from single muscle fiber segments. Electrophoresis. 1993;14(1-2):56-64
  89. 89. Vikhlyantsev IM, Podlubnaya ZA. Composition of titin isoforms of skeletal and cardiac muscles in pathologies. Biophysics. 2008;53(6):592-597
  90. 90. Latsabidze IL. Electron microscopic study of the structure of myosin containing filaments as part of anisotropic discs of vertebrate striated muscles: Candidate’s dissertation [in Russian]. Pushchino: Erevan State University; 1985. p. 153
  91. 91. Wang K. Sarcomere-associated cytoskeletal lattices in striated muscle. Review and hypothesis. Cell and Muscle Motility. 1985;6:315-369
  92. 92. Linke WA, Ivemeyer M, Labeit S, Hinssen H, Rüegg JC, Gautel M. Actin-titin interaction in cardiac myofibrils: Probing a physiological role. Biophysical Journal. 1997;73(2):905-919
  93. 93. Fritz JD, Swartz DR, Greaser ML. Factors affecting polyacrylamide gel electrophoresis and electroblotting of high-molecular-weight myofibrillar proteins. Analytical Biochemistry. 1989;180(2):205-210
  94. 94. King NL, Kurth L. SDS gel electrophoresis studies of connectin. In: Parry D, Creamer LK, editors. Fibrous Proteins: Scientific, Industrial and Medical Aspects. Vol. 2. New York: Academic; 1980. pp. 57-66
  95. 95. Mitsuhashi T, Kasai M, Hatae K. Detection of giant myofibrillar proteins connectin and nebulin in fish meat by electrophoresis in 3-5 gradient sodium dodecyl sulfate polyacrylamide slab gels. Journal of Agricultural and Food Chemistry. 2002;50(26):7499-7503
  96. 96. Vikhlyantsev IM. Polymorphism of titin of striated muscles under normal conditions, during adaptation and pathology: Doctoral’s dissertation [in Russian]. Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino; 2011. p. 235
  97. 97. Greaser ML, Warren CM. Efficient electroblotting of very large proteins using a vertical agarose electrophoresis system. Methods in Molecular Biology. 2009;536:221-227. DOI: 10.1007/978-1-59745-542-8_24
  98. 98. Greaser ML, Warren CM. Protein electrophoresis in agarose gels for separating high molecular weight proteins. Methods in Molecular Biology. 2012;869:111-118. DOI: 10.1007/978-1-61779-821-4_10
  99. 99. Neagoe C. Biochemical and mechanical investigation of cardiac titin isoforms. Doctor scientiarum humanarum (Dr. sc. hum.). Heidelberg: Ruprecht-Karls-Universität; 2008

Written By

Ivan M. Vikhlyantsev and Zoya A. Podlubnaya

Submitted: 29 January 2018 Reviewed: 23 February 2018 Published: 05 November 2018